Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
[PubMed] [Frontiers] [PubMed] Setin-Suero E, Surez-Pinilla M, Surez-Pinilla P, Crespo-Facorro B, Ayesa-Arriola R
Patients receiving semaglutide also achieved a whopping 12.5% reduction in their total body weight over the 72-week study period
Although GLP-1 therapies are effective, they can be expensive
Approval (2017) FDA News Release (March 8th, 2024): FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight FDA News Release (August 15th, 2025): FDA Approves Treatment for Serious Liver Disease Known as MASH OZEMPIC (semaglutide) injection, for subcutaneous use
Semaglutide works by mimicking a hormone your body naturally produces to tell your brain when youre full
In practical terms it also means that mature brain function should not be investigated until full maturation has occurred, which in mice and rats is at a postnatal age of 34 weeks
